|
|
Article: VALIRX PLC - European Technology Patent for Nucleosomics.
- Article from:
- PR Newswire UK Disclose
- Article date:
- November 12, 2007
CopyrightCOPYRIGHT 2007 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
For immediate release - 7.00am, 12th November 2007
ValiRx Plc
("ValiRx")
European Technology Patent for Nucleosomics
ValiRx (AIM: VAL), the cancer therapeutics company, today announces that
following the announcement on 15 October 2007 regarding the signing of a full
license agreement with Chroma Therapeutics Ltd ("Chroma") to commercialise
Nucleosomics1, a non-invasive diagnostic technology patent developed by Chroma,
ValiRx has been allowed the European patent for its Nucleosomics technology
patent application.
Nucleosomics complements ValiRx's existing cancer diagnostics ...